GlucoTrack, Inc. (GCTK) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
GCTK Revenue Growth
Revenue Breakdown
GCTK's revenue distribution by segment and geography
By Geography
GCTK Revenue Analysis (2013–2024)
As of May 8, 2026, GlucoTrack, Inc. (GCTK) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q2 2025) recorded $0 in revenue.
Looking at the longer-term picture, GCTK's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $611,689 in 2016.
When compared to Healthcare sector peers including DXCM (+16.2% YoY), PODD (+31.9% YoY), and TNDM (-6.8% YoY). Compare GCTK vs DXCM →
GCTK Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| $0 | - | - | - | ||
| $4.7B | +16.2% | +19.3% | 19.6% | ||
| $2.7B | +31.9% | +24.5% | 17.5% | ||
| $1.0B | -6.8% | +15.3% | -7.7% | ||
| $35M | +78.9% | +48.1% | -193.8% |
GCTK Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $-36,000 | - | $-14,547,000 | - |
| 2023 | $0 | - | $-13,000 | - | $-7,104,000 | - |
| 2022 | $0 | - | $-23,000 | - | $-4,432,000 | - |
| 2021 | $0 | - | $0 | - | $-4,040,000 | - |
| 2020 | $0 | -100.0% | $-47,000 | - | $-3,132,000 | - |
| 2019 | $208K | +378.3% | $208K | 100.0% | $3.5M | 1685.6% |
| 2018 | $43K | -92.6% | $-52,075 | -119.7% | $6.5M | 15035.4% |
| 2017 | $589K | -3.6% | $449K | 76.2% | $10.6M | 1794.2% |
| 2016 | $612K | +327.3% | $552K | 90.3% | $5.7M | 924.6% |
| 2015 | $143K | +139.5% | $98K | 68.6% | $4.7M | 3251.7% |
See GCTK's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GCTK Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GCTK vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonGCTK — Frequently Asked Questions
Quick answers to the most common questions about buying GCTK stock.
Is GCTK's revenue growth accelerating or slowing?
GCTK TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is GCTK's long-term revenue growth rate?
GlucoTrack, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is GCTK's revenue distributed by segment?
GCTK reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.